CytoSorbentsRecent Data Breaches and Security Report

https://cytosorbents.com  ᛫  Manufacturing
Last updated October 26, 2018

Company Details

Company Overview

Cytosorbents Corporation is a publicly traded company (NasdaqCM: CTSO) located in Monmouth Junction, New Jersey. Cytosorbents has created a blood purification technology based on biocompatible, porous polymer beads that act like sponges in an attempt to remove harmful substances from the blood.CytoSorb, the company's first product to market, received its CE mark approval in 2011.CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency (DARPA) for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins.

Valuation

Employees

CEO

Phillip Chan

Location

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like CytoSorbents

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for CytoSorbents

Get full security report ›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.